According to the Zhitong Finance App, Zhongke Biotech (01237) announced the results for the year ended December 31, 2023. The group achieved revenue of 298 million yuan (RMB, same below) during the period, a year-on-year decrease of 36.02%; shareholders' losses of 2.364 million yuan, a year-on-year narrowing of 63.95%; a basic loss of 0.03 yuan per share;

The announcement said that in the reporting year, wood products revenue was still the Group's largest source of revenue. Revenue in this category fell 36.0% to $295 million (2022: $461 million), accounting for 99.2% (2022:99.1%) of total sales for the reporting year, mainly due to declining sales in Australia.